CD21 (ABT113R) rabbit mAb

    • Catalog No.:YM7253
    • Applications:IHC; ELISA
    • Reactivity:Human;
      • Target:
      • CD21
      • Fields:
      • >>Complement and coagulation cascades;>>Hematopoietic cell lineage;>>B cell receptor signaling pathway;>>Epstein-Barr virus infection
      • Gene Name:
      • CR2
      • Protein Name:
      • Complement receptor type 2 (Cr2) (Complement C3d receptor) (Epstein-Barr virus receptor) (EBV receptor) (CD antigen CD21)
      • Human Gene Id:
      • 1380
      • Human Swiss Prot No:
      • P20023
      • Immunogen:
      • Synthesized peptide derived from human CD21 AA range:400-500
      • Specificity:
      • This antibody detects endogenous levels of CD21
      • Formulation:
      • PBS, 50% glycerol, 0.05% Proclin 300, 0.05%BSA
      • Source:
      • Monoclonal, Rabbit IgG1, Kappa
      • Dilution:
      • IHC 1:100-500, ELISA 1:5000-20000
      • Purification:
      • Recombinant Expression and Affinity purified
      • Storage Stability:
      • -15°C to -25°C/1 year(Do not lower than -25°C)
      • Other Name:
      • C3DR;CD 21;CD21;Complement C3d receptor 2;Complement C3d receptor;Complement component (3d/Epstein Barr virus) receptor 2;Complement receptor type 2;CR;Cr2;CR2_HUMAN;CVID7;EBV receptor;EBV-R;Epstein Barr virus receptor;Epstein-Barr virus receptor;EVBR;SLEB9
      • Background:
      • This gene encodes a membrane protein, which functions as a receptor for Epstein-Barr virus (EBV) binding on B and T lymphocytes. Genetic variations in this gene are associated with susceptibility to systemic lupus erythematosus type 9 (SLEB9). Alternatively spliced transcript variants encoding different isoforms have been found for this gene.[provided by RefSeq, Sep 2009],
      • Function:
      • disease:Genetic variations in CR2 are associated with susceptibility to systemic lupus erythematosus type 9 (SLEB9) [MIM:610927]. Systemic lupus erythematosus (SLE) is a chronic autoimmune disease with a complex genetic basis. SLE is an inflammatory, and often febrile multisystemic disorder of connective tissue characterized principally by involvement of the skin, joints, kidneys, and serosal membranes. It is thought to represent a failure of the regulatory mechanisms of the autoimmune system.,function:Receptor for complement C3Dd, for the Epstein-Barr virus on human B-cells and T-cells and for HNRPU. Participates in B lymphocytes activation.,similarity:Belongs to the receptors of complement activation (RCA) family.,similarity:Contains 15 Sushi (CCP/SCR) domains.,tissue specificity:Mature B-lymphocytes, T-lymphocytes, pharyngeal epithelial cells, astrocytes and follicular dendritic cells
      • Subcellular Location:
      • Membranous
      • Expression:
      • Mature B-lymphocytes, T-lymphocytes, pharyngeal epithelial cells, astrocytes and follicular dendritic cells of the spleen.
      • Products Images
      • Immunohistochemical analysis of paraffin-embedded human Tonsil. 1, Antibody was incubated at 4° overnight. 2, Citrate buffer of pH6.0 was used for antigen retrieval. 3,Secondary antibody was diluted at 1:200(room temperature, 30min).
      • Immunohistochemical analysis of paraffin-embedded human Tonsil. 1, Antibody was incubated at 4° overnight. 2, Citrate buffer of pH6.0 was used for antigen retrieval. 3,Secondary antibody was diluted at 1:200(room temperature, 30min).